Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP ® drug delivery and VivaGel ®. Starpharma is developing VIRALEZE™, an antiviral nasal spray for COVID-19 which is complementary to vaccines …